John G. Stratton
At a glance: John G. Stratton is Director at Abbott Laboratories (ABT). Their latest SEC Form 4, filed Jun 18, 2026, reported a purchase of $174K. On file: 1 purchase line ($174K) and 0 sale lines ($0).
Disclosed holdings: about $2.4M of ABT stock: 23,319 shares reported on their latest Form 4 (filed Jun 18, 2026), valued at the Nov 20, 2026 close of $104.17. This counts only ABT shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Abbott Laboratories (ABT)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
John G. Stratton's InsiderPrint
3 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.
Reading this print: Almost only buys, trading about once a year, typically $174K a trade.
- Bump outward: a purchase (3)
- Dent inward: a sale (0)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Jeffrey C. LightcapDirector · HTFL · 100% match
- Prithvi GandhiCFO · TREX · 99% match
- Lori WittmanDirector · AHRT · 99% match
- Beth J. KaplanDirector · CROX · 98% match
- Steven P. StanbrookDirector · PRMB · 98% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Every purchase since 2026
From the SEC's insider data sets: each open-market buy by John G. Stratton, matched to how the stock did over the next 90 days against the S&P 500.
1 of 1 buy beat the S&P 500 (100%), median +15.6% vs. the index. Small sample: treat with care. All insider buys: 46%.
| Stock | Filed | 90 days vs. S&P 500 |
|---|---|---|
| ABT | Jun 18, 2026 | +15.6% |
Buys made close together in one stock count once. Price-only returns; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 18SEC | ABTAbbott LaboratoriesFirst buy | Buy | 2,00023,319 held (+9%) | $86.82 | $174K | +20.0% |
- Buy
Director John G Stratton bought $174K of ABT at $86.82 — first open-market purchase in our records.
Follow John G. Stratton
Get one email when John G. Stratton files a new purchase or sale. Free.
At most one email a day about John G. Stratton, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.